Foghorn Therapeutics Inc. (FHTX)

Foghorn Therapeutics Inc. (FHTX) is a healthcare company (biotechnology) based in the United States. The share price is $1.83, up 2.23% on the day, which values the company at $109.73M. Price as of 18 Nov 2026, 12:30 UTC, from Yahoo Finance.

Key facts

Share price
$1.83+2.23% today
Market value
$109.73M
P/E ratio
20.3×last 12 months
Funk Score
51/100
200-week average
$5.5267% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Foghorn Therapeutics Inc. in more detail

FHTX trades at 20.3× its last twelve months' earnings, -1.6× next year's expected earnings, 1.0× sales. It sits 67% below its 200-week average of $5.52.

Over the last five fiscal years Foghorn Therapeutics Inc. has compounded revenue 135.1% a year. Its Funk Score is 51 out of 100 (financial strength 3.8, profitability 2.5, growth 8.9, each out of 10).

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

Foghorn Therapeutics Inc. (FHTX): questions and answers

What is FHTX's P/E ratio?

Foghorn Therapeutics Inc. trades at 20.3× its last twelve months' earnings and -1.6× next year's expected earnings.

What is Foghorn Therapeutics Inc.'s market cap?

Foghorn Therapeutics Inc. is valued at $109.73M at a share price of $1.83.

Is FHTX above its 200-week moving average?

No. FHTX is 66.9% below its 200-week average of $5.52. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Foghorn Therapeutics Inc. growing?

Over the last five fiscal years Foghorn Therapeutics Inc.'s revenue grew 135.1% a year.

Does FHTX pay a dividend?

Foghorn Therapeutics Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Foghorn Therapeutics Inc. (FHTX) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/FHTX

Underlying data: Yahoo Finance; company filings with the SEC.